| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |